Use of Physiologically-Based Pharmacokinetic Modeling (PBPK) in Conjunction with CellCiphr HCS to Predict Compound Safety Thresholds and Improve Lead Optimization

1 Sept 2014

This poster demonstrates that the Cloe®PK can be mathematically inverted in order to predict an oral dosing regimen from a given Cmax safety threshold.

Links

Tags